A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

INTRODUCTION: Acute lung injury and acute respiratory distress syndrome are common complications in patients with coronavirus disease 2019 (COVID-19). Poor outcomes in patients with COVID-19 are associated with cytokine release syndrome. Binding of interleukin-8 (CXCL8/IL-8) to its chemokine recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Landoni, Giovanni, Piemonti, Lorenzo, Monforte, Antonella d’Arminio, Grossi, Paolo, Zangrillo, Alberto, Bucci, Enrico, Allegretti, Marcello, Goisis, Giovanni, Gavioli, Elizabeth M., Patel, Neal, De Pizzol, Maria, Pasedis, Georgea, Mantelli, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135383/
https://www.ncbi.nlm.nih.gov/pubmed/35618953
http://dx.doi.org/10.1007/s40121-022-00644-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135383/
https://www.ncbi.nlm.nih.gov/pubmed/35618953
http://dx.doi.org/10.1007/s40121-022-00644-6

Ejemplares similares